Research Alliance II priced its IPO of 13 million shares of Class A common stock at $10 each.
Shares begin trading today on the Nasdaq under RACB.
The offering is expected to close March 22.
Sponsored by RA Capital Management, the SPAC is targeting a business combination with one or more businesses in the healthcare industry. Read more.
